Martini Jeffrey S — SEC insider filings

SEC reporting owner CIK 1914560. 4 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-12-17 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
PALVELLA THERAPEUTICS, INC. (PVLA)Chief Scientific Officer4—13 legs · 12,500 sh · $2,083,07610

Insider filings — Martini Jeffrey S

FiledFormIssuerReported transactionsSource
2026-11-124PALVELLA THERAPEUTICS, INC. (PVLA)Option exercise (M): 4,266 @ $7.53 · Option exercise (M): 1,984 @ $9.79 · Sale (S): 100 @ $163.34 · Sale (S): 1,449 @ $164.85 · Sale (S): 1,651 @ $165.85 · Sale (S): 1,500 @ $166.91 · +13 moreEDGAR
2026-02-094PALVELLA THERAPEUTICS, INC. (PVLA)Grant/award (A): 64,318 (derivative) @ $0EDGAR
2025-02-104/APALVELLA THERAPEUTICS, INC. (PVLA)Grant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2024-12-174PALVELLA THERAPEUTICS, INC. (PVLA)Grant/award (A): 126,416 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1914560 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs